About Sigyn Therapeutics Inc. (SIGY) data
Data as of July 15, 2026.
Sigyn Therapeutics Inc. (SIGY) has 1.50K shares sold short as of the latest FINRA settlement report on July 15, 2026. Short interest has decreased by 78.84% compared with the prior settlement. At the current average daily volume, covering all open short positions would take about 0.01 days (days to cover).
Recent SIGY short interest history
| Settlement date | Short interest | Change | Days to cover |
|---|---|---|---|
| Jul 15, 2026 | 1,501 | -78.84% | 1.00 |
| Jun 30, 2026 | 7,095 | -54.45% | 1.00 |
| Jun 15, 2026 | 15,577 | -51.87% | 1.00 |
| May 29, 2026 | 32,362 | 1,083.25% | 1.00 |
| May 15, 2026 | 2,735 | -86.36% | 1.00 |
| Apr 30, 2026 | 20,045 | 660.72% | 1.00 |
| Apr 15, 2026 | 2,635 | 0.00% | 1.00 |
| Mar 31, 2026 | 2,635 | -91.01% | 1.00 |
| Mar 13, 2026 | 29,321 | 30,764.21% | 1.00 |
| Feb 27, 2026 | 95 | 0.00% | 1.00 |
| Feb 13, 2026 | 95 | 0.00% | 1.00 |
| Jan 30, 2026 | 95 | -65.45% | 1.00 |
Full history, charts, and borrow-fee detail are on the SIGY short interest page.
Frequently asked questions
What is the current short interest in SIGY?
As of the latest FINRA settlement dated July 15, 2026, SIGY had approximately 1,501 shares sold short. Short interest data is reported by FINRA twice per month.
How much does it cost to short SIGY?
The latest borrow fee (cost to borrow) for SIGY is 7.80% per year, based on IBKR data. Fees can change throughout the trading day as shares are borrowed and returned.
What is the days to cover ratio for SIGY?
Days to cover for SIGY is approximately 0.01 days. This estimates how many trading days it would take short sellers to buy back all outstanding short shares at the current average daily volume.
Is SIGY a short squeeze candidate?
A squeeze needs shorts that are hard to close. SIGY trades about 118,747 shares a day and would take roughly 0.01 days to unwind current short positions, at a current borrow fee of 7.80%. Higher days-to-cover and a rising borrow fee together are the setup to watch; neither alone is enough.